Literature DB >> 12814991

The natural history of type-specific human papillomavirus infections in female university students.

Harriet Richardson1, Gail Kelsall, Pierre Tellier, Hélène Voyer, Michal Abrahamowicz, Alex Ferenczy, François Coutlée, Eduardo L Franco.   

Abstract

Little is known about the average duration of type-specific human papillomavirus (HPV) infections and their patterns of persistence. The objectives of this study were to evaluate the rate of acquisition and clearance of specific HPV types in young women. Female university students (n = 621) in Montreal were followed for 24 months at 6-month intervals. At each visit, a cervical specimen was collected. HPV DNA was detected using the MY09/MY11 PCR protocol followed by typing for 27 HPV genotypes by a line blot assay. The Kaplan-Meier technique was used to estimate the cumulative probability of acquiring or clearing a HPV infection considering types individually or in high-risk (HR) or low-risk (LR) groups defined by oncogenic potential. Incidence rates were 14.0 cases/1000 women-months (95% confidence interval, 11.4-16.3) and 12.4 cases/1000 women-months (95% confidence interval, 10.4-14.8) for acquiring HR and LR HPV infections, respectively. The 24-month cumulative rates of acquisition were highest for HPV-16 (12%), HPV-51, and HPV-84 (8%). Of the incident infections, HPV-16 was the most persistent (mean duration, 18.3 months), followed by HPV-31 and HPV-53 (14.6 and 14.8 months, respectively). HPV-6 and HPV-84 had the shortest mean duration time (<10 months) The mean durations of incident, same-type LR or HR HPV infections were 13.4 months and 16.3 months, respectively. Whereas the majority of episodes with a type-specific HPV infection cleared within 2 years, there were many women who were either reinfected with a new HPV genotype or presumably experienced reactivation of their initial infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12814991

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  103 in total

Review 1.  [HPV-associated squamous cell carcinogenesis].

Authors:  G Assmann; K Sotlar
Journal:  Pathologe       Date:  2011-09       Impact factor: 1.011

2.  The females against cancer educational series: a qualitative evaluation of mother/daughter knowledge and perceptions of human papillomavirus and its related cancers.

Authors:  Tasha R Louis-Nance; Minnjuan W Flournoy; Karen S Clinton; Krystle Hightower; Neethu Sebastian; Larrell L Wilkinson; Saundra H Glover
Journal:  J Natl Med Assoc       Date:  2012 Mar-Apr       Impact factor: 1.798

Review 3.  Management of low-grade cervical lesions in young women.

Authors:  Susie Lau; Eduardo L Franco
Journal:  CMAJ       Date:  2005-09-27       Impact factor: 8.262

4.  [Anal HPV infections].

Authors:  Felix Aigner; Friedrich Conrad; Andreas Widschwendter; Robert Zangerle; Bettina Zelger; Alfred Haidenberger; Sebastian Roka; Kurt Heim; Reinhard Höpfl; Martin Klimpfinger; Yves Marcus Rigler; Hugo Bonatti; Johann Pfeifer; Andrea Maier; Reinhard Kirnbauer; Andreas Salat
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

5.  Alterations of T-cell surface markers in older women with persistent human papillomavirus infection.

Authors:  Ana Cecilia Rodríguez; Alfonso J García-Piñeres; Allan Hildesheim; Rolando Herrero; Matthew Trivett; Marcus Williams; Ivannia Atmella; Margarita Ramírez; Maricela Villegas; Mark Schiffman; Robert Burk; Enrique Freer; José Bonilla; Concepción Bratti; Ligia A Pinto
Journal:  Int J Cancer       Date:  2011-02-01       Impact factor: 7.396

6.  Difficulties in estimating the male-to-female sexual transmissibility of human papillomavirus infection.

Authors:  Ali Rowhani-Rahbar; James P Hughes; Laura A Koutsky
Journal:  Sex Transm Dis       Date:  2009-04       Impact factor: 2.830

Review 7.  Cervical cancer screening.

Authors:  Dorothy J Wiley; Bradley J Monk; Emmanuel Masongsong; Kristina Morgan
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

8.  Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial.

Authors:  A Sargent; A Bailey; A Turner; M Almonte; C Gilham; H Baysson; J Peto; C Roberts; C Thomson; M Desai; J Mather; H Kitchener
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

9.  Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study.

Authors:  Philip E Castle; Patti E Gravitt; Diane Solomon; Cosette M Wheeler; Mark Schiffman
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

10.  Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women.

Authors:  Ann Nielsen; Thomas Iftner; Christian Munk; Susanne K Kjaer
Journal:  Sex Transm Dis       Date:  2009-10       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.